Clinical Trials Browser

Phase 2 × Epirubicin × Tumor-Agnostic × Clear all

NCT01869192 2019-09-24

Phase II Trial for Large ER-Negative Breast Cancers

Phase 2 Completed

72 enrolled 6 charts

Neoplasms